tiprankstipranks
Sirona Biochem Corp (DE:ZSB)
FRANKFURT:ZSB

Sirona Biochem (ZSB) Stock Price & Analysis

1 Followers

ZSB Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€0.04 - €0.13
Previous Close€0.05
Volume0.00
Average Volume (3M)29.99K
Market Cap
€10.85M
Enterprise Value€11.96M
Total Cash (Recent Filing)C$571.49K
Total Debt (Recent Filing)C$2.18M
Price to Earnings (P/E)-6.6
Beta-1.15
Jun 26, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding254,054,505
10 Day Avg. Volume0
30 Day Avg. Volume29,994
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)-7.08
Price to Sales (P/S)336.02
Price to Cash Flow (P/CF)-18.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

15.37%0.00%0.00%84.63%
15.37% Insiders
0.00% Other Institutional Investors
84.63% Public Companies and
Individual Investors

ZSB FAQ

What was Sirona Biochem Corp’s price range in the past 12 months?
Sirona Biochem Corp lowest stock price was €0.04 and its highest was €0.13 in the past 12 months.
    What is Sirona Biochem Corp’s market cap?
    Currently, no data Available
    When is Sirona Biochem Corp’s upcoming earnings report date?
    Sirona Biochem Corp’s upcoming earnings report date is Jun 26, 2024 which is in 60 days.
      How were Sirona Biochem Corp’s earnings last quarter?
      Currently, no data Available
      Is Sirona Biochem Corp overvalued?
      According to Wall Street analysts Sirona Biochem Corp’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Sirona Biochem Corp pay dividends?
        Sirona Biochem Corp does not currently pay dividends.
        What is Sirona Biochem Corp’s EPS estimate?
        Sirona Biochem Corp’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Sirona Biochem Corp have?
        Sirona Biochem Corp has 245,398,530 shares outstanding.
          What happened to Sirona Biochem Corp’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Sirona Biochem Corp?
          Currently, no hedge funds are holding shares in DE:ZSB
          ---

          Sirona Biochem Stock Smart Score

          N/A
          Not Ranked
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Technicals

          SMA
          Negative
          20 days / 200 days
          Momentum
          -35.00%
          12-Months-Change

          Fundamentals

          Return on Equity
          Trailing 12-Months
          Asset Growth
          -20.04%
          Trailing 12-Months

          Company Description

          Sirona Biochem Corp

          Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. It has a business presence in Canada and France.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Sirona Biochem
          Avivagen
          BriaCell Therapeutics
          Resverlogix
          Helix BioPharma
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis